|
1) Ewend MG, Elbabaa S, Carey LA. Current treatment paradigms for the management of patients with brain metastases. Neurosurgery. 2005; 57(5 Suppl): S66-77
|
|
|
|
2) 中洲庸子. 転移性脳腫瘍に対する放射線治療. 脳神経外科. 2007; 35: 7-16
|
|
|
|
|
|
3) Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999; 49: 8-31
|
|
|
|
|
4) Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phse III results of the RTOG 9508 randomised trial. Lancet. 2004; 363: 1665-72
|
|
|
|
|
|
5) 厚生労働省ホームページ 統計. 第6表死亡数・死亡率. H19年. http://www.mhlw.go.jp/toukei/
|
|
|
|
|
|
6) 成田善孝. 転移性脳腫瘍治療の問題点と手術適応. 脳外誌. 2007; 16: 820-7
|
|
|
|
|
|
7) Gabos Z, Sinha R, Hanson J, et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol. 2006; 24: 5658-63
|
|
|
|
|
|
8) Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery. Ann Neurol. 1993; 33: 583-90
|
|
|
|
|
|
9) Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA. 1998; 280: 1485-9
|
|
|
|
|
|
10) Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999; 45: 427-34
|
|
|
|
|
|
11) Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA. 2006; 295: 2483-91
|
|
|
|
|
|
12) Muacevic A, Wowra B, Siefert A, et al. Microsurgery plus whole brain irradiation versus gamma knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol. 2008; 87: 299-307
|
|
|
|
|
|
13) Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007; 68: 1388-95
|
|
|
|
|
|
14) Grosshans DR, Meyers CA, Allen PK, et al. Neurocognitive function in patients with small cell lung cancer. Effect of prophylactic cranial irradiation. Cancer. 2008; 112: 589-95
|
|
|
|
|
|
15) Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncoloby group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745-51
|
|
|
|
|
|
16) Rades D, Pluemer A, Veninga T, et al. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer. 2007; 110: 2285-92
|
|
|
|
|
|
17) Sperduto PW, Berkey B, Gaspar LE, et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1, 960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008; 70: 510-4
|
|
|
|
|
|
18) 宮北康二, 成田善孝, 田部井勇助, 他. 転移性脳腫瘍の浸潤能とMatrix metalloproteinaseの発現について. 第23回日本脳腫瘍病理学会抄録. 東京; 2005
|
|
|
|
|
|
19) Sills AK. Current treatment approaches to surgery for brain metastases. Neurosurgery. 2005; 57(5 Suppl): S24-32
|
|
|
|
|
|
20) 中洲庸子, 三矢幸一, 堀口聡士. 転移性脳腫瘍に対する摘出術64件の検討. 第66回日本脳神経外科学会総会抄録. 東京; 2007
|
|
|
|
|
|
21) Pompili A, Carapella CM, Cattani F, et al. Metastases to the cerebellum. Results and prognostic factors in a consecutive series of 44 operated patients. J Neurooncol. 2008; 88: 331-7
|
|
|
|
|
|
22) Khuntia D, Brown P, Li J, et al. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol. 2006; 24: 1295-304
|
|
|
|
|
|
23) Pease NJ, Edwards A, Moss LJ. Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review. Palliat Med. 2005; 19: 288-99
|
|
|
|
|
|
24) Mehta MP, Khuntia D. Current strategies in whole-brain radiation therapy for brain metastases. Neurosurgery. 2005; 57(5 Suppl): S33-44
|
|
|
|
|
|
25) Brown PD, Asher AL, Farace E. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed. Int J Radiat Oncol Biol Phys. 2008; 70: 1305-9
|
|
|
|
|
|
26) Brown PD, Brown CA, Pollock BE, et al. Stereotactic radiosurgery for patients with “radioresistant"brain metastases. Neurosurgery. 2002; 51: 656-65
|
|
|
|
|
|
27) 芹沢 徹, 永野 修, 樋口佳則, 他. 転移性脳腫瘍に対するガンマナイフ単独治療成績. 予防的全脳照射を併用しない局所治療プロトコールの適応と限界. 脳外誌. 2007; 16: 833-9
|
|
|
|
|
|
28) Peereboom DM. Chemotherapy in brain metastases. Neurosurgery. 2005; 57(5 Suppl): S54-65
|
|
|
|
|
|
29) 大堀久詔, 高橋 信, 石岡千加史. 転移性脳腫瘍に対する化学療法の役割. 脳外誌. 2007; 16: 840-8
|
|
|
|
|
|
30) Nguyen TD, DeAngelis LM. Brain metastases. Neurol Clin. 2007; 25: 1173-92
|
|
|
|
|
|
31) Paul MJ, Summers Y, Calvert AH, et al. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res. 2002; 12: 175-8
|
|
|
|
|
|
32) Nathoo N, Chahlavi A, Barnett GH, et al. Pathology of brain metastases. J Clin Pathol. 2005; 58: 237-42
|
|
|
|
|
|
33) Chiu CH, Tsai CM, Chen YU, et al. Gefitinib is active in patients with brain metastasis from non-small cell lung cancer and response is related to skin toxicity. Lung Cancer. 2005; 47: 129-38
|
|
|
|
|
|
34) 加藤達雄, 中島賢憲, 吉村光太郎, 他. ゲフィチニブの再投与にて脳転移が消失した肺腺癌の1例. 日呼吸会誌. 2005; 43: 700-3
|
|
|
|
|
35) 三矢幸一, 堀口聡士, 中洲庸子, 他. 固形癌による癌性髄膜症に対するMTX髄注＋全脳照射療法の工夫. 第45回日本がん治療学会総会抄録. 京都; 2007
|
|
|
|
|
|
36) Shinoura N, Tabei Y, Yamada R, et al. Continuous intrathecal treatment with methotrexate via subcutaneous port: implication for leptomeningeal dissemination of malignant tumors. J Neurooncol. 2008; 87: 309-16
|
|
|
|
|
|
37) Soffietti R, Cornu P, Delattre JY, et al. EFNS guidelines on diagnosis and treatment of brain metastases: report of an EFNS task force. Eur J Neurol. 2006; 13: 674-81
|
|
|
|
|
|
38) Ewend MG, Morris DE, Carey LA, et al. Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy. J Nation Comprehensive Cancer Network. 2008; 6: 505-13
|
|
|
|
|
|
39) National Comprehensive Cancer Network. Central Nervous System Cancers. Version 1. 2008. Available at http://www.nccn.org/professionals/
|
|
|
|
|